We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Impairment of lung diffusion capacity, which correlated ...
CHARLOTTESVILLE, Va., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative clinical stage biopharmaceutical company developing ...
But out of 300,000 high-probability images tested, researchers found a 0.03% memorization rate. However, Carlini’s results are not as clear-cut as they may first appear. Discovering instances of ...
CHARLOTTESVILLE, Va., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback